ITP three R's: regulation, routing, rituximab.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2008-05-155770PMID 18684874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

  2008cited by this paper
• Rituximab in the treatment of autoimmune haematological disorders

  2008cited by this paper
• Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high‐dose dexamethasome

  2007cited by this paper
• Hemostasis, Thrombosis, and Vascular Biology

  2007cited by this paper
• Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.

  2007cited by this paper
• Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura

  2006cited by this paper
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

  2006cited by this paper
• Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.

  2004cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Opinion-regulatory lymphocytes: Natural versus adaptive regulatory T cells

  2003cited by this paper
• An essential role for Scurfin in CD4+CD25+ T regulatory cells

  2003cited by this paper
• Supporting Online Material

  2002cited by this paper

• Low-dose rituximab in steroid-refractory chronic graft-versus-host disease.

  2023cites this paper
• Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia

  2023cites this paper
• Crosstalk Between Platelets and Microbial Pathogens

  2020cites this paper
• Translational and clinical advances in JAK‐STAT biology: The present and future of jakinibs

  2018cites this paper
• Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine.

  2016cites this paper
• The JAK-STAT pathway: impact on human disease and therapeutic intervention.

  2015cites this paper
• SUPPLEMENT PAPER: 4TH ICIS EXPERT MEETING________ Oxidative Stress and Immune Thrombocytopenia

  2013cites this paper
• Oxidative stress and immune thrombocytopenia.

  2013cites this paper
• Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders

  2010cites this paper
• REVelation (del: 5q).

  2009cites this paper
• Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells

  2009cites this paper